Emerging Therapies Transforming the Sarcoma Drugs Industry
Immunotherapy is emerging as a promising treatment approach.Checkpoint inhibitors are being evaluated for sarcoma cases.Combination therapies are improving patient survival outcomes. The Sarcoma Drugs Market is projected to witness steady growth, registering a CAGR of 7.9% from 2025 to 2031. The market size is expected to expand from US$ XX million in 2024 to US$ XX million by 2031, driven by...
0 Σχόλια 0 Μοιράστηκε 34 Views 0 Προεπισκόπηση
Zepky https://zepky.com